Literature DB >> 16027692

The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates.

Patrick A Flynn1, Ralph L da Graca, Peter A M Auld, Mirjana Nesin, Charles S Kleinman.   

Abstract

OBJECTIVE: To test the utility of the bedside plasma concentration of B-type natriuretic peptide (BNP) assay as a screen for patent ductus arteriosus (PDA) in premature neonates. STUDY
DESIGN: Newborn infants admitted to the neonatal intensive care unit (NICU) had paired echocardiography and BNP measurements at enrollment and every 4 to 5 days.
RESULTS: Twenty neonates (gestational age approximately 28.6 weeks and birth weight approximately 1161 g) had 81 paired echocardiography and BNP determinations. BNP ranged from 5 to 3900 pg/mL. Fifty-six of 81 echocardiograms showed PDA. Significant correlations were found between BNP and ductal size and degree of shunting. Correlation was greater in infants >2 days of age. BNP >300 pg/mL predicted significant PDA, whereas BNP <105 pg/mL predicted absence of significant PDA.
CONCLUSION: Bedside measurement of BNP correlates with magnitude of PDA in premature newborns, particularly beyond day 2, and may be useful in guiding diagnostic and management strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16027692     DOI: 10.1016/j.jpeds.2005.03.040

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

Review 1.  Plasma B-type natriuretic peptides in children with cardiovascular diseases.

Authors:  Bibhuti B Das
Journal:  Pediatr Cardiol       Date:  2010-10-07       Impact factor: 1.655

2.  N-terminal-pro-B-type natriuretic peptide in premature patent ductus arteriosus: a physiologic biomarker, but is it a clinical tool?

Authors:  Cathy Hammerman; Irena Shchors; Michael S Schimmel; Ruben Bromiker; Michael Kaplan; Amiram Nir
Journal:  Pediatr Cardiol       Date:  2009-10-27       Impact factor: 1.655

3.  Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment.

Authors:  Nami Jhaveri; Anita Moon-Grady; Ronald I Clyman
Journal:  J Pediatr       Date:  2010-09       Impact factor: 4.406

4.  The relationship between BNP, NTproBNP and echocardiographic measurements of systemic blood flow in very preterm infants.

Authors:  K König; K J Guy; G Walsh; S M Drew; A Watkins; C P Barfield
Journal:  J Perinatol       Date:  2014-02-06       Impact factor: 2.521

5.  Serial N-terminal pro-brain natriuretic peptide measurement as a predictor of significant patent ductus arteriosus in preterm infants beyond the first week of life.

Authors:  Johannes Buca Letshwiti; Jan Sirc; Ruth O'Kelly; Jan Miletin
Journal:  Eur J Pediatr       Date:  2014-06-05       Impact factor: 3.183

6.  Nesiritide for the treatment of pulmonary hypertension and cor pulmonale in an infant.

Authors:  E W Reynolds; E T Conely; M Vranicar
Journal:  Pediatr Cardiol       Date:  2007-03-20       Impact factor: 1.655

7.  Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.

Authors:  Sarah Louise Harris; Kiran More; Bronwyn Dixon; Richard Troughton; Chris Pemberton; John Horwood; Nicola Ellis; Nicola Austin
Journal:  Eur J Pediatr       Date:  2018-01-19       Impact factor: 3.183

8.  Natriuretic peptide C receptor in the developing sheep lung: role in perinatal transition.

Authors:  Bobby Mathew; Christopher A D'Angelis; Satyan Lakshminrusimha; Peter A Nickerson; June J Sokolowski; Vasantha H S Kumar; Huamei Wang; Karen A Wynn; Bruce A Holm; Rita M Ryan
Journal:  Pediatr Res       Date:  2017-05-31       Impact factor: 3.756

9.  Serum brain natriuretic peptide and risk of acute kidney injury after cardiac operations in children.

Authors:  Christoph P Hornik; Catherine D Krawczeski; Michael Zappitelli; Kwangik Hong; Heather Thiessen-Philbrook; Prasad Devarajan; Chirag R Parikh; Uptal D Patel
Journal:  Ann Thorac Surg       Date:  2014-04-13       Impact factor: 4.330

10.  The Use of N-Terminal-Pro-BNP in Preterm Infants.

Authors:  Afif El-Khuffash; Eleanor Molloy
Journal:  Int J Pediatr       Date:  2009-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.